GBuddy imo there's only 1 proxy. Lets state it again so

A Bra Revolution or Just Another Launch? I'll admit it, lingerie isn't the usual breakfast discussion for me, but Vanity Fair Lingerie's move with their new Flawlessly Smooth™ Bra piqued my interest. Announced in Bowling Green, Kentucky, on November 2, 2026, and set against the lavish backdrop of an upcoming New York City event cohosted by Cosmopolitan, it's less about...

Lighting a Fire Under Complacency Elections often bring out the big dogs, but rarely do you see a grassroots campaign like Extreme Weather Survivors’ 'Stolen Summers' making such ripples. Rallying from New York to North Carolina and everywhere in between, this campaign has been a clarion call for communities ravaged by Mother Nature's fury. And let's face it, the...

Another Day, Another Big Hire in D.C. You'd think the revolving doors at these law firms were tied to Wall Street's cycles. Latham & Watkins, one heavyweight in the legal arena, is pulling a classic power move, snapping up Steven Johnson for their Washington, D.C. office. He ain't just some guy off the street; Johnson's got a résumé that reads like a textbook on federal...

A Veteran's Task in a New Territory Piling onto its international ambitions, XPENG has roped in Lee Man-sik, a seasoned auto industry professional, to break into South Korea. South Korea isn’t just another market—it’s one of the toughest stages for the automotive industry. The customers there are sharp, with a keen eye for tech and quality. So XPENG, trading under...

Financial Milestones and Market Insights Boy, if you're not watching TETRA Technologies (NYSE:TTI) right now, you're probably missing out on a real barnstormer of a financial report. The numbers are looking chalkboards-be-damned stellar! They’ve just notched their finest third quarter in a decade, bringing in revenues through the roof at $168 million—an impressive 10%...

Looking Ahead to Protalix's Q3 Revelation Nobody's pretending it's a cakewalk to stay ahead in the biopharma sector, especially when you're tangoing with the unpredictable world of rare disease therapeutics. But here we are, with Protalix BioTherapeutics scheduling their third-quarter financial results announcement for November 10, 2026. If you've been tracking them—or...

SIMPLAAFY Trial Makes Waves in Cardiac Care Alright, let's dig into the heart of the matter—pun fully intended. Boston Scientific (NYSE:BSX) just rolled out some head-turning results from their SIMPLAAFY study, which evaluates the WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device. What’s so special, you ask? Well, it’s all about simplifying the post-surgery...

MIAX's Strategic Move Towards Binary Options Ah, that's something that might just shake things up a bit. On November 3rd, 2026, MIAMI International Holdings (NYSE: MIAX) made the headlines by filing with the SEC to offer cash-settled binary index options. Now, if you're not new to the trading game, you know that anything involving SEC registration gets the blood pumping....

The Future of Drug Development: AI's New Role When it comes to pharmaceutical R&D, Some outfits are playing pin the tail on the donkey, but Differentia Bio over here is sharpening the pin with some futuristic gadgetry. Yep, they're jazzing up the game with AI-powered digital twins, building lifelike disease environments that predict therapeutic outcomes with precision...

A Big Play in the Valve Game Straight out of the industrial playbook, Platinum Equity swoops in with its latest acquisition of Warren Valve, yanking it from the clutches of Allied Group. It's not every day you see a move like this in the flow control world. Yeah, you heard that right—flow control. The kind of business that’s all about ensuring the right stuff gets to...

BOXX Insurance Embraces Growth in the U.S. Market BOXX Insurance is strategically enhancing its footprint in the U.S. market by appointing key leadership positions aimed at innovation within the cyber insurance space. This forward-thinking global insurtech is committed to delivering unique solutions tailored for both businesses and consumers. The expansion signifies a...

Celleste Bio™ Achieves Landmark Cocoa Butter Production Celleste Bio™, an innovative cocoa technology company, has proudly announced a groundbreaking milestone in transforming the cocoa supply chain. The firm has unveiled its first-ever chocolate grade cocoa butter produced using cutting-edge plant cell culture technology, making waves in the agro-technological...

Understanding VINCI's Share Capital and Voting Rights Total VINCI, a prominent French public limited company, is recognized for its significant role in infrastructure and construction. With a robust share capital totaling €1,474,737,915.00, the company's extensive operational framework has positioned it as a leader in its sector. Share Structure Overview As of the...

Rezolve Ai's Daniel Wagner Advocates for UK AI Advancement In a significant announcement, Daniel Wagner, CEO and founder of Rezolve Ai (NASDAQ: RZLV), expressed strong support for the UK government's initiative to establish a National Data Library. This decision aims to enhance access to high-quality data for developers, a move Wagner characterizes as a pivotal moment for...

Future Innovations in Art and Technology The China (Hangzhou) Art and Technology Biennale recently launched at the Yuhang Art Museum, serving as a significant platform for cultural exchange and artistic expression. This remarkable event, organized by the China Academy of Art (CAA) along with various art institutions and governmental bodies, showcases a diverse range of...